Correlation Between Pmv Pharmaceuticals and Allarity Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Allarity Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Allarity Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Allarity Therapeutics, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Allarity Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Allarity Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Allarity Therapeutics.
Diversification Opportunities for Pmv Pharmaceuticals and Allarity Therapeutics
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Pmv and Allarity is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Allarity Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allarity Therapeutics and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Allarity Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allarity Therapeutics has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Allarity Therapeutics go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Allarity Therapeutics
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.51 times more return on investment than Allarity Therapeutics. However, Pmv Pharmaceuticals is 1.98 times less risky than Allarity Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Allarity Therapeutics is currently generating about -0.16 per unit of risk. If you would invest 149.00 in Pmv Pharmaceuticals on October 24, 2024 and sell it today you would lose (12.00) from holding Pmv Pharmaceuticals or give up 8.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Allarity Therapeutics
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Allarity Therapeutics |
Pmv Pharmaceuticals and Allarity Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Allarity Therapeutics
The main advantage of trading using opposite Pmv Pharmaceuticals and Allarity Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Allarity Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will offset losses from the drop in Allarity Therapeutics' long position.| Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
| Allarity Therapeutics vs. Nuvalent | Allarity Therapeutics vs. Arcellx | Allarity Therapeutics vs. Vaxcyte | Allarity Therapeutics vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |